Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors

被引:168
|
作者
Miyazaki, M
Jacobson, MJ
Man, WC
Cohen, P
Asilmaz, E
Friedman, JM
Ntambi, JM [1 ]
机构
[1] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA
[3] Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA
[4] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.M304724200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stearoyl-CoA desaturase (SCD) is the rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids. Thus far, three isoforms of SCD (SCD1, SCD2, and SCD3) have been identified and characterized. Regulation of the SCD1 isoform has been shown to be an important component of the metabolic actions of leptin in liver, but the effects of leptin on SCD isoforms in other tissues have not been investigated. We found that although the mRNA levels of SCD1 and SCD2 were not affected by leptin deficiency in the hearts of ob/ob mice, the SCD activity and levels of monounsaturated fatty acids were increased, implying the existence of another SCD isoform. This observation has led to the cDNA cloning and characterization of a fourth SCD isoform (SCD4) that is expressed exclusively in the heart. SCD4 encodes a 352-amino acid protein that shares 79% sequence identity with the SCD1, SCD2, and SCD3 isoforms. Liver X receptor alpha (LXRalpha) agonists and a high carbohydrate fat-free diet induced SCD4 expression, but unlike SCD1, SCD4 expression was not repressed by dietary polyunsaturated fatty acids. SCD4 mRNA levels were elevated 5-fold in the hearts of leptin-deficient ob/ob mice relative to wild type controls. Treatment of ob/ob mice with leptin decreased mRNA levels of SCD4, whereas levels of SCD1 and SCD2 were not affected. Furthermore, in the hearts of SCD1-deficient mice, SCD4 mRNA levels were induced 3-fold, whereas the levels of SCD2 were not altered. The current studies identify a novel heart-specific SCD isoform that demonstrates tissue-specific regulation by leptin and dietary factors.
引用
收藏
页码:33904 / 33911
页数:8
相关论文
共 9 条
  • [1] Identification and characterization of a novel bovine stearoyl-CoA desaturase isoform with homology to human SCD5
    Lengi, Andrea J.
    Corl, Benjamin A.
    LIPIDS, 2007, 42 (06) : 499 - 508
  • [2] Identification and characterization of a novel bovine stearoyl-CoA desaturase isoform with homology to human SCD5
    Lengi, Andrea
    Corl, Benjamin A.
    FASEB JOURNAL, 2007, 21 (05): : A701 - A701
  • [3] Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1)
    Voss, Marc D.
    Zoller, Gerhard
    Matter, Hans
    Herling, Andreas W.
    Biemer-Daub, Gabriele
    Pfenninger, Anja
    Haag-Diergarten, Silke
    Keil, Stefanie
    Kohlmann, Markus
    Schmidts, Hans-Ludwig
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 707 (1-3) : 140 - 146
  • [5] Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2
    Tabor, DE
    Kim, JB
    Spiegelman, BN
    Edwards, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) : 20603 - 20610
  • [6] Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1) (vol 707, pg 140, 2013)
    Voss, Marc D.
    Zoller, Gerhard
    Matter, Hans
    Herling, Andreas W.
    Biemer-Daub, Gabriele
    Pfenninger, Anja
    Haag-Diergarten, Silke
    Keil, Stefanie
    Kohlmann, Markus
    Schmidts, Hans-Ludwig
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 715 (1-3) : 39 - 40
  • [7] Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation
    Uto, Yoshikazu
    Ogata, Tsuneaki
    Kiyotsuka, Yohei
    Miyazawa, Yuriko
    Ueno, Yuko
    Kurata, Hitoshi
    Deguchi, Tsuneo
    Yamada, Makiko
    Watanabe, Nobuaki
    Takagi, Toshiyuki
    Wakimoto, Satoko
    Okuyama, Ryo
    Konishi, Masahiro
    Kurikawa, Nobuya
    Kono, Keita
    Osumi, Jun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4159 - 4166
  • [8] Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4′-piperidine]
    Uto, Yoshikazu
    Kiyotsuka, Yohei
    Ueno, Yuko
    Miyazawa, Yuriko
    Kurata, Hitoshi
    Ogata, Tsuneaki
    Deguchi, Tsuneo
    Yamada, Makiko
    Watanabe, Nobuaki
    Konishi, Masahiro
    Kurikawa, Nobuya
    Takagi, Toshiyuki
    Wakimoto, Satoko
    Kono, Keita
    Ohsumi, Jun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 746 - 754
  • [9] Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats
    Uto, Yoshikazu
    Ogata, Tsuneaki
    Kiyotsuka, Yohei
    Ueno, Yuko
    Miyazawa, Yuriko
    Kurata, Hitoshi
    Deguchi, Tsuneo
    Watanabe, Nobuaki
    Konishi, Masahiro
    Okuyama, Ryo
    Kurikawa, Nobuya
    Takagi, Toshiyuki
    Wakimoto, Satoko
    Ohsumi, Jun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 341 - 345